No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients.
| Autor: | Weiner, Myron F., Galasko, Douglas, Thal, Leon J., Tractenberg, Rochelle E., Sano, Mary, Logsdon, Rebecca, Teri, Linda, Gamst, Anthony, Thomas, Ron |
|---|---|
| Předmět: |
PSYCHIATRIC drugs
ALZHEIMER'S disease AGITATION (Psychology) TRANQUILIZING drugs ANTIPSYCHOTIC agents TRAZODONE HALOPERIDOL BEHAVIOR therapy PSYCHOLOGY of caregivers CLINICAL trials COMPARATIVE studies INTERVIEWING LONGITUDINAL method RESEARCH methodology MEDICAL cooperation PSYCHOLOGICAL tests PSYCHOMOTOR disorders RESEARCH TIME EVALUATION research RANDOMIZED controlled trials PSYCHOLOGICAL factors THERAPEUTICS PSYCHOLOGY |
| Zdroj: | Journal of Geriatric Psychiatry & Neurology; Summer2002, Vol. 15 Issue 2, p95-98, 4p |
| Abstrakt: | Th determine if teaching caregivers behavior management techniques (BMTs) reduces long-term psychotropic use in Alzheimer's disease (AD) patients, we examined 12-month follow-up data from a 4-month randomized study comparing placebo, BMTs, trazodone, and haloperidol for the treatment of agitated behaviors in persons with AD. After 4 months, treatment was allowed with any agent. Between 42.8% and 51% of AD patients received additional psychotropics between 4 and 12 months. The relative risk of being prescribed any psychotropic drug after the 4-month trial was at or about 1.0 for subjects in each drug arm or placebo arm versus BMTs. We concluded that teaching caregivers BMTs did not diminish long-term prescription of psychotropic drugs. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|